Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001905389 | SCV002133291 | uncertain significance | Pyogenic arthritis-pyoderma gangrenosum-acne syndrome | 2021-07-04 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The proline amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. This variant has not been reported in the literature in individuals affected with PSTPIP1-related conditions. This variant is present in population databases (rs746898326, ExAC 0.002%). This sequence change replaces threonine with proline at codon 333 of the PSTPIP1 protein (p.Thr333Pro). The threonine residue is weakly conserved and there is a small physicochemical difference between threonine and proline. |